Concepedia

Author

Martin Wiselka

Leicester Royal InfirmaryORCID

Also Known As

Abid Hussain, Andrew Ustianowski, Clare McAdam, Data collection leader, Elizabeth E. Fry, Kate Tatham, Lawrence Wilson, Leon Peto, M J Wiselka, M WIselka

167

Publications

8.7K

Citations

37

H-Index

71

Concepts

All Affiliations

Leicester Royal InfirmaryUniversity Hospitals of Leicester NHS TrustUniversity of LeicesterUniversity of OxfordUniversity of Nottingham
MW

About

Martin Wiselka is an author at Leicester Royal Infirmary specializing in medicine, infection control, and epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

19

2.6K

2

Epidemiology

7

7

2K

3

Public Health

4

4

1.1K

4

Allergy

1

1

32

5

Health Policy

1

1

48

Martin Wiselka

×

44

Publications

4.3K

Citations

29

H-Index

YearCitations

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

Victoria Hall, Sarah Foulkes, Ayoub Saei,

The Lancet

2021

829

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Victoria Hall, Sarah Foulkes, André Charlett,

The Lancet

2021

732

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial

Peter Horby, Marion Mafham, Louise Linsell,

2020

249

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Rishi K Gupta, Ewen M. Harrison, Antonia Ho,

The Lancet Respiratory Medicine

2021

224

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Chloë I. Bloom, Thomas M Drake, Annemarie B Docherty,

The Lancet Respiratory Medicine

2021

192

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Guy Thwaites, Matthew Scarborough, Alexander J. Szubert,

The Lancet

2017

183

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani,

The Lancet Infectious Diseases

2022

170

Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study

Christopher Martin, David R. Jenkins, Jatinder S. Minhas,

EClinicalMedicine

2020

169

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Thomas M Drake, Aya Riad, Cameron J Fairfield,

The Lancet

2021

161

Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting

Jan Schmid, Frank C. Odds, Martin Wiselka,

Journal of Clinical Microbiology

1992

151

Page 1